Brovana

(arformoterol tartrate) Inhalation Solution

  • Patient Medication Guide
  • Important Patient Information
  • Contact Us
  • Healthcare Professionals
  • About Brovana
  • What is COPD?
  • For Caregivers

Sitemap

Home > Sitemap

  • smallmediumlarge
  • Share
  • Print

About BROVANA

  • Treating COPD with BROVANA
  • How to Use BROVANA
  • How to Get BROVANA
  • BROVANA FAQs
  • How to Use a Nebulizer
  • Cleaning Your Nebulizer

What is COPD?

  • COPD Symptoms
  • The Causes of COPD
  • COPD Stages
  • COPD Treatment Options
  • Living with COPD
  • COPD FAQs
  • COPD Resources

For Caregivers

  • COPD Caregivers Tips
  • COPD FAQs for Caregivers

BROVANA is a medicine called a long-acting beta2-agonist or LABA. BROVANA is used long term, twice a day (morning and evening), in controlling symptoms of chronic obstructive pulmonary disease (COPD) in adults with COPD. BROVANA is for inhalation use only through a standard jet nebulizer connected to an air compressor and should not be swallowed or injected.

IMPORTANT PATIENT INFORMATION

People with asthma who take long-acting beta2 adrenergic agonist (LABA) medicines such as BROVANA have an increased risk of death from asthma problems. It is not known if LABA medicines, such as BROVANA, increase the risk of death in people with COPD.

BROVANA does not relieve sudden symptoms of COPD and should not be used more than twice a day. Always have a short-acting beta2-agonist with you to treat sudden symptoms.

Get emergency medical care if breathing problems worsen quickly or you use your short-acting beta2-agonist medicine but it does not relieve your breathing problems.

Do not stop using BROVANA unless told to do so by your healthcare provider because your symptoms might get worse.

When you are using BROVANA twice a day, do not use other medicines that contain a LABA for any reason.

BROVANA should not be used in children.

Tell your doctor if you have a heart condition or high blood pressure. Some people may experience increased blood pressure, heart rate or changes in heart rhythm. In COPD clinical trials, the five most common adverse events reported with BROVANA were pain, chest pain, back pain, diarrhea, and sinusitis. Other possible side effects include headache, tremor, nervousness, and dizziness.

Please see the full Prescribing Information and Medication Guide for BROVANA.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

The health information contained herein is provided for educational purposes only and is not intended to replace discussions with a healthcare provider.

All decisions regarding patient care must be made with a healthcare provider, considering the unique characteristics of the patient. BROVANA is a medicine used to treat COPD in adults. Remember that no medicine is right for everyone. Only your doctor can prescribe BROVANA for you.

  • COPD Resources
  • get savings on brovana
  • Contact Us
  • Terms of Use
  • Privacy Statement
  • Medical Disclaimer
  • Site Map
  • Unsubscribe

BROVANA is a registered trademark of Sunovion Pharmaceuticals Inc. Sunovion Pharmaceuticals Inc. is a U.S. subsidiary of Dainippon Sumitomo Pharma Co. Ltd. ©2011 Sunovion Pharmaceuticals Inc. All rights reserved. 07/11 BRO093-11.